Strategic advisory for biomass productivity, crop improvement and R&D translation

Many research and innovation programs generate valuable data, but still struggle to convert insight into measurable gains in productivity, product quality or commercial deployment.

The problem is often not a lack of science. It is a lack of alignment between the biological constraint, the technology pipeline, the investment strategy and the time required for delivery.

I advise research organisations, ag-biotech companies, bioeconomy ventures and agricultural innovation programs on how to improve biomass productivity, strengthen R&D performance and translate biological insight into practical outcomes.

Where is the real constraint?

In complex biological systems, the limiting factor is not always where attention is focused. A program may invest heavily in discovery, omics, genetics or new technology, while the true constraint sits elsewhere — in carbon allocation, sink strength, growth dynamics, crop physiology, field performance, processing quality or market alignment.

I help organisations diagnose these constraints and build clearer pathways from scientific opportunity to practical impact.

Areas of advisory support

Biomass productivity and crop improvement

I support programs that aim to increase biomass yield, improve crop performance or develop new biomass-based production systems. This includes reviewing biological constraints, assessing whether sufficient variation exists in breeding or germplasm pipelines, and identifying where advanced technologies such as genome editing may or may not be justified.

R&D strategy and portfolio review

Many R&D portfolios contain strong individual projects but weak strategic alignment. I help organisations review whether projects are connected to the main productivity or commercial objective, whether delivery timelines are realistic, and whether resources are being allocated to the right stage of the technology pipeline.

Translation from discovery to impact

Discovery does not automatically lead to deployment. I advise on how to connect molecular, physiological and field-level understanding into decision-ready strategies that can guide investment, product development and commercialisation.

Bioeconomy and biomass processing

Biomass value depends not only on yield, but also on composition, water content, harvest stage, logistics and processing consequences. I help organisations evaluate biomass quality and identify where biological variation affects downstream value.

Typical questions I help address

• What is the real biological or technical constraint limiting productivity?
• Is the current R&D portfolio aligned with the main problem?
• Are discovery projects realistically connected to field or commercial outcomes?
• Does the crop improvement pipeline contain enough useful variation?
• Where should investment be placed: breeding, physiology, agronomy, biotechnology, processing or market development?
• Are timelines for technology delivery realistic?
• Is the biomass being evaluated in a way that reflects its true processing value?
• What evidence is needed before committing to the next stage of development?

How I work

My advisory approach combines scientific depth with strategic clarity.

I review the biological system, the available evidence, the technology pipeline and the intended outcome. The aim is not simply to add more information, but to identify the decision points that matter.

This may involve:

• independent review of R&D programs
• assessment of crop or biomass productivity constraints
• review of technology pipelines
• evaluation of biomass composition and processing implications
• strategic advice on discovery-to-deployment pathways
• preparation of technical reports, board papers or investment-facing summaries
• facilitation of internal strategy discussions

Who this is for

This advisory work is suited to:

• agricultural research organisations
• crop improvement programs
• ag-biotech and bioeconomy companies
• biomass processing ventures
• industry bodies and funding organisations
• investors assessing biological or biomass-based opportunities

Advisory focus

My strongest contribution is at the interface between biology, productivity and strategy.

I bring together crop physiology, biomass formation, carbon allocation, composition, technology development and executive-level R&D experience to help organisations make better decisions about where to focus effort and investment.

The goal is simple:

Clearer diagnosis, better-aligned technology pipelines, and faster movement from insight to impact.